TBlack
tea consumption and cancer risk: A prospective study In a prospective cohort study, men of Japanese ancestry were clinically examined from 1965 to 1968. For 7,833 of these men, data on black tea consumption habits were recorded. Since 1965, newly diagnosed cancer incidence cases have been identified: 152 colon 151 lung, 149 prostate, 136 stomach, 76 rectum, 57 bladder, 30 pancreas, 25 liver, 12 kidney and 163 at other (miscellaneous) sites. Compared to almost-never drinkers, men habitually drinking black tea more than once/say has an increased relative risk (RR) for rectal cancer (RR = 4.2). This positive association (P = 0.0007) could not be accounted for by age or alcohol intake. We also observed a weaker but significant negative association of black tea intake and prostate cancer incidence (P = 0.020). There were no significant associations between black tea consumption and cancer at any other site. The Anti-Cancer
Effects of Tea Animal in vivo studies and human epidemiological observations indicated potent anticancer effects for tea. Here we demonstrate that epigallocatechin gallate (EGCG), a major tea catechin, strongly and directly inhibits telomerase, an enzyme essential for unlocking the proliferative capacity of cancer cells by maintaining the tips of their chromosomes. Telomerase inhibition was elaborated in a cell-free system (cell extract) as well as in living cells. In addition, the continued growth of two representative human cancer cell lines, U937 monoblastoid leukaemia cells and H29 colon adenocarcinoma cells, in the presence of non-toxic concentrations of EGCG showed life span limitations accompanied with telomere shortening, chromosomal abnormalities, and expression of the senescence-associated beta-galactosidase. It is suggested that telomerase inhibition could be one the major mechanisms underlying the anticancer effects of tea. Copywright 1998 Academic Press. Author Polyphenols
as cancer chemopreventive agents - a review. This article summarises
available data on the chemopreventive efficacies of tea polyphenols,
curcumin and ellagic acid in various model systems. Emphasis is placed
upon the anticarcinogenic activity of these polyphenols and their
proposed mechanism(s) of action. Tea is grown in about 30 countries
and, next to water, is the most widely consumed beverage in the world.
Tea is manufactured as either green, black, or oolong; black tea represents
approximately 80% of tea products. Epidemiological studies, though
inconclusive, suggest a protective effect of tea consumption on human
cancer. Experimental studies of the antimutagenic and anticarcinogenic
effects of tea have been conducted principally with green tea polyphenols
(GTPs). GTPs exhibit antimutagenic activity in vitro, and they inhibit
carcinogen-induced skin, lung, forestomach, oesophagus, duodenum and
colon tumours in rodents. In addition, GTPs inhibit TPA-induced skin
tumour promotion in mice. Although several GTPs possess anticarcinogenic
activity, the most active is (-)-epigallocatechin-3-gallate (EGCG),
the major constituent in the GTP fraction. Several mechanisms appear
to be responsible for the tumour-inhibitory properties of GTPs, including
enhancement of antioxidant (glutathione peroxidase, catalase and quinone
reductase) and phase II (glutathion-S-transferase) enzyme activities;
inhibition of chemically induced lipid peroxidation; inhibition of
irradiation- and TPA-induced epidermal ornithine decarboxylase (ODC)
and cyclooxygenase activities; inhibition of protein kinase C and
cellular proliferation; anti-inflammatory activity; and enhancement
of gap junction intercellular communication.
Previous research
suggested that the mutagenicity of some genotoxic carcinogens, mainly
heterocyclic amines, was decreased by green or black tea extracts,
or tea polyphenol fractions. Thus, it seemed important to test a variety
of genotoxic carcinogens with distinct chemical structures and means
of biochemical activation as regards modification of mutagenicity
in appropriate strains of Salmonella typhimurium by 3 concentrations
of polyphenols 60, 100, or B, standard commercial polyphenol preparations
from green or black tea. Polyphenols sharply decreased the mutagenicity
of a number of aryl- and heterocyclic amines, of aflatoxin B1, benzo
(a) pyrene, 1,2- dibromoethane, and more selectively, of 2-nitropropane,
all involving an induced rat liver S9 fraction. Good inhibition was
found with 2 nitrosamines that required a hamster S9 fraction for
biochemical activation. No effect was found with 1-nitropyrene, and
with the direct acting (no S9) 2-chloro-4-methyl-thiobutanoic acid.
Thus, with some exceptions, polyphenols considerably decreased the
mutagenicity of diverse types of carcinogens.
| |||||